Skip to main content

Day: December 10, 2024

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity

Press Release – No. 12 / 2024 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesityZealand Pharma announces that the first participant has been enrolled in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity. The Phase 2b ZUPREME-1 trial is designed to evaluate five target doses of petrelintide up to 9 mg over 42 weeks of treatment. Completion of enrollment into ZUPREME-1 is expected in the first half of 2025.Copenhagen, Denmark, December 10, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that the first participant has been enrolled in ZUPREME-1, a global Phase 2b trial in people...

Continue reading

Longer-term Novartis Kisqali® NATALEE data show durable reduction in distant recurrence in broad population of patients with early breast cancer

Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between anatomical stages1Real-world 5-year distant recurrence data in high-risk patients with HR+/HER2- early breast cancer (EBC), regardless of nodal status, highlights importance of adding a CDK4/6 inhibitor to endocrine therapy for all eligible patients2Late-breaking Kisqali data presentations at SABCS follow recent FDA and EMA approvals and recognition by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®*) as only Category 1 preferred adjuvant treatment for both N+ and high-risk N0 disease in combination with AI3Basel, December 10, 2024 – Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial...

Continue reading

Professional Diversity Network, Inc. Announces Additional Investment in QBSG Limited

CHICAGO, Dec. 10, 2024 (GLOBE NEWSWIRE) — Professional Diversity Network, Inc. (NASDAQ: IPDN) (“PDN” or the “Company”), a leader in the development and operation of online and in-person diversity talent networks, which provide access to networking, training, educational, and employment opportunities for diverse individuals, today announced that the Company, pursuant to a Profit Participation Agreement (the “Agreement”) with Koala Malta Limited, has purchased a 6% right in QBSG Limited (the “Target”, previously Koala Crypto Limited)’s distributions and dividends. The investment, which took place on December 5, 2024, involved the issuance of 1,136,363 shares of the Company’s common stock, valued at $500,000, and a cash payment of $700,000. In addition to the 9% stock purchase in the Target on September 27, 2022, PDN now owns right...

Continue reading

Acquisition by Energy Capital Partners and Co-Investors Approved by the High Court of Justice of England and Wales

Acquisition by Energy Capital Partners and Co-Investors Approved by the High Court of Justice of England and Wales December 10, 2024 – Atlantica Sustainable Infrastructure plc (NASDAQ: AY) (“Atlantica” or the “Company”), announced today that the High Court of Justice of England and Wales (the “Court”) has sanctioned the scheme of arrangement providing for the proposed acquisition of the Company by California Buyer Limited (“Bidco”), a vehicle controlled by funds managed by Energy Capital Partners (“ECP”) and which includes a large group of institutional co-investors (the “Transaction”), at a hearing held earlier today. On May 27, 2024, Atlantica entered into an agreement pursuant to which 100% of its shares would be acquired by Bidco for $22 per share in cash. Closing of the Transaction will become effective upon the court order being...

Continue reading

Ultra-Low Temperature Freezers Market Set For 4.84% Growth, Reaching $820 Million By 2032 Globally

Ultra-Low Temperature Freezers Market top companies: WR International LLC (US), Thermo Fisher Scientific (US), Eppendorf AG (Germany), Stirling Ultracold (Greece), PHC Corporation (US), Arctiko (UK), Helmer Scientific (US), BINDER GmbH (Germany), Labcold (UK), Esco Micro Pte Ltd (US) Gondia, India, Dec. 10, 2024 (GLOBE NEWSWIRE) — Ultra-Low Temperature Freezers Market size was valued at USD 0.53 Billion in 2023 and is poised to grow from USD 0.56 Billion in 2024 to USD 0.82 Billion by 2032, at a CAGR of 4.84 % during the forecast period (2024-2032) by IMIR Market Research Pvt. Ltd. Global Ultra Low Temperature Freezers Market Size, Share & Trends Analysis Report By Product Type (Upright Freezers, Chest Freezers), By Application (Biopharmaceuticals, Research Laboratories, Clinical Applications), By Technology (Cascade Refrigeration,...

Continue reading

Banzai Announces Definitive Agreement to Acquire OpenReel, Growing TTM Revenue 152% to $10.9M

Banzai Adds Enterprise-Grade Branded Video Creation and Management Solution OpenReel to Growing Product Family SEATTLE, Dec. 10, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today announced that it has signed a definitive agreement to acquire OpenReel, a leading digital video creation platform. OpenReel enables companies to rapidly create high-quality, branded video content. Their solution allows companies to direct, record, create, and collaborate on high-definition video projects, dramatically reducing the time to create brand-compliant video content. OpenReel’s enterprise customer base includes global organizations, such as Bristol Myers Squibb, Ingram Micro, DXC Technology, Insider...

Continue reading

Car Air Purifier Market to Witness 17.4% CAGR by 2031 | SkyQuest Technology

Westford,USA, Dec. 10, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Car Air Purifier Market size will attain the value of USD 26.21 Billion by 2031, with a CAGR of 17.4% during the forecast period (2024-2031). The main objective of the car air purifier market trend is to address the growing concerns about air pollution and its impact on human health, especially in densely populated urban areas. Increasing vehicle emissions, industrial pollution and the presence of allergens are increasing the need for effective air purification solutions in vehicles. Several factors are driving the growth of the car air purifier market.Consumers are becoming increasingly aware of the importance of indoor air quality and its impact on health. As people spend a significant amount of time traveling in their cars, the demand for car air purifiers...

Continue reading

Academy Sports + Outdoors Reports Third Quarter 2024 Results

Net Sales Decline (3.9)%; Comparable Sales of (4.9)% GAAP Diluted EPS of $0.92, or $0.98 Adjusted Diluted EPS1 Year-to-Date GAAP Operating Cash Flow +29%; Year-to-Date Adjusted Free Cash Flow1 +67% vs LY Authorizes New $700 Million Share Repurchase Program Plans to Open 20 to 25 New Stores in Fiscal 2025 KATY, Texas, Dec. 10, 2024 (GLOBE NEWSWIRE) — Academy Sports and Outdoors, Inc. (Nasdaq: ASO) (“Academy” or the “Company”) today announced its results for the third quarter ended November 2, 2024. Financial and operational highlights include:Opened 16 stores in fiscal 2024, consistent with plan, including further expansion into Ohio Narrowed fiscal 2024 guidance to Net Sales of $5.89B to $5.94B“We delivered third quarter sales in line with expectations and were encouraged to see an improvement...

Continue reading

Seaspan Selects KVH to Equip Fleet with OneWeb Low Earth Orbit Solution

MIDDLETOWN, R.I., Dec. 10, 2024 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI), today announced that Seaspan Corporation (Seaspan), a world leading independent containership lessor, has signed an agreement to equip its fleet with the OneWeb advanced low earth orbit (LEO) satellite offering from KVH. This marks the next step in Seaspan’s drive to deliver shore-like Internet connectivity at sea, supporting its digital transformation strategy and augmenting its fleet’s existing LEO services. Chad Impey, Senior Vice President for Global Sales at KVH, commented, “We are proud to support Seaspan with the planned deployment of OneWeb service and hardware as part of our fully integrated KVH ONE® multi-orbit, multi-channel network solution. It is the most recent example of our long-time, beneficial partnership in support of Seaspan’s...

Continue reading

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare’s Immunoprint test for prognostication of disease recurrence in early-stage melanoma patients to better guide treatment decisions and potentially increase access to life saving therapies for those patients at high risk of developing metastatic disease MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma, today announced an exclusive global license agreement to develop and commercialize NeraCare’s Immunoprint test on Akoya’s multiplexed immunofluorescent platform. Building on the research collaboration between the companies announced...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.